Tambong, Marilou .
HRN: 27-85-31 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/10/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
10/10/2025
10/12/2025
IV
600mg
Q8H
S/P BKA, Left
Waiting Final Action
Indication: Empiric Type of Infection: Bone & Joint Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes